[1] Makowski L, Hotamisligil GS. Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses. J Nutr , 2004, 134(9): 2464S-2468S. [2] Xu AM, Wang Y, Xu JY, Stejskal D, Tam S, Zhang JL, Wat NMS, Wong WK, Lam KSL. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem , 2006, 52(3): 405-413. [3] Baxa CA, Sha RS, Buelt MK, Smith AJ, Matarese V, Chinander LL, Boundy KL, Bernlohr DA. Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry , 1989, 28(22): 8683-8690. [4] Coe NR, Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta , 1998, 1391(3): 287-306. [5] Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab , 2000, 11(5): 175-180. [6] 张军, 董飚, 张红, 储冬生, 徐国庆, 龚道清, 段修军, 赵旭庭, 顾志良. 鸭A-FABP基因的克隆及其组织表达. 畜牧兽医学报, 2008, 39(6): 819-822. [7] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2( -Δ ΔC T method. Methods , 2001, 25(4): 402-408. [8] Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM. Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA , 1986, 83(11): 3786-3790. [9] Melki SA, Abumrad NA. Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J Lipid Res , 1993, 34(9): 1527-1534. [10] Distel RJ, Robinson GS, Spiegelman BM. Fatty acid regulation of gene expression. Transcriptional and post- transcriptional mechanisms. J Biol Chem , 1992, 267(9): 5937-5941. [11] Bernlohr DA, Bolanowski MA, Kelly TJ Jr, Lane MD. Evidence for an increase in transcription of specific mRNAs during differentiation of 3T3-L1 preadipocytes. J Biol Chem , 1985, 260(9): 5563-5567. [12] Hertzel AV, Bennaars-Eiden A, Bernlohr DA. Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells. J Lipid Res , 2002, 43(12): 2105-2111. [13] Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2 , the adipocyte fatty acid binding protein. Science , 1996, 274(5291): 1377-1379. [14] Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res , 1999, 40(5): 967-972. [15] Shaughnessy S, Smith ER, Kodukula S, Storch J, Fried SK. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes , 2000, 49(6): 904-911. [16] Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology , 2000, 141(9): 3388-3396. [17] Scheja L, Makowski L, Uysal KT, Wiesbrock SM, Shimshek DR, Meyers DS, Morgan M, Parker RA, Hotamisligil GS. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes , 1999, 48(10): 1987-1994. [18] Baar RA, Dingfelder CS, Smith LA, Bernlohr DA, Wu C, Lange AJ, Parks EJ. Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. Am J Physiol Endocrinol Metab , 2005, 288(1): E187-E193. [19] Smith AJ, Thompson BR, Sanders MA, Bernlohr DA. Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem , 2007, 282(44): 32424-32432. [20] Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia , 2013, 56(1): 10-21. [21] Fu YC, Luo LH, Luo NL, Garvey WT. Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis , 2006, 188(1): 102-111. [22] Pearson SL, Cawthorne MA, Clapham JC, Dunmore SJ, Holmes SD, Moore GB, Smith SA, Tadayyon M. The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats. Biochem Biophys Res Commun , 1996, 229(3): 752-757. [23] 闫桂蕊, 张小东, 蔡海燕, 朱维良, 王贺瑶. 糖尿病和动脉粥样硬化的潜在靶标——FABP4(aP2). 生命科学, 2009, 21(2): 270-275. [24] Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ, Lane MD. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev , 1989, 3(9): 1323-1335. [25] Yeung DC, Xu AM, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol , 2007, 27(8): 1796-1802. [26] Xu AM, Tso AWK, Cheung BMY, Wang Y, Wat NMS, Fong CHY, Yeung DCY, Janus ED, Sham PC, Lam KSL. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation , 2007, 115(12): 1537-1543. [27] Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA , 2006, 103(18): 6970-6975. [28] Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol , 2002, 13(2): 141-147. [29] Pelton PD, Zhou LB, Demarest KT, Burris TP. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun , 1999, 261(2): 456-458. [30] Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng MQ, Ince TA, Kozakewich H, Bischoff J, Cataltepe S. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J , 2009, 23(11): 3865-3873. [31] Fu YC, Luo NL, Lopes-Virella MF. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res , 2000, 41(12): 2017-2023. [32] Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol , 2005, 25(6): 1220-1224. [33] Llaverias G, Noé V, Peñuelas S, Vázquez-Carrera M, Sánchez RM, Laguna JC, Ciudad CJ, Alegret M. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem Biophys Res Commun , 2004, 318(1): 265-274. [34] Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J Biol Chem , 2005, 280(13): 12888-12895. |